7655-72-3

Basic information

• Product Name: 3,5-Dichloro-2-(trifluoromethyl)pyridine
• Synonyms: 3,5-Dichloro-2-(trifluoromethyl)pyridine
• CAS NO: 7655-72-3
• Molecular Formula: C6H2Cl2F3N
• Molecular Weight: 216
• Mol File: 7655-72-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 182.3°Cat760mmHg
• Flash Point: 64°C
• Appearance: /
• Density: 1.542g/cm³
• Vapor Pressure: 1.11mmHg at 25°C
• Refractive Index: 1.47
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3,5-Dichloro-2-(trifluoromethyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 3,5-Dichloro-2-(trifluoromethyl)pyridine(7655-72-3)
• EPA Substance Registry System: 3,5-Dichloro-2-(trifluoromethyl)pyridine(7655-72-3)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 7655-72-3(Hazardous Substances Data)

Usage

General Description

3,5-Dichloro-2-(trifluoromethyl)pyridine is a chemical compound with the molecular formula C6H2Cl2F3N. It is a pyridine derivative that contains two chlorine atoms and one trifluoromethyl group. This chemical is often used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has also been studied for its potential use as a building block in the development of new materials and organic compounds. 3,5-Dichloro-2-(trifluoromethyl)pyridine is known for its high reactivity and is handled and stored with caution due to its potential hazardous properties.

InChI:InChI=1/C6H2Cl2F3N/c7-3-1-4(8)5(12-2-3)6(9,10)11/h1-2H

Upstream product

• 2457-47-8 3,5-dichloropyridine 
• 2926-29-6 Langlois reagent 
• 14482-51-0 3,5-dichloro-2-bromopyridine 
• 1214350-54-5 3,5-dichloro-2-iodopyridine 
• 81290-20-2 (trifluoromethyl)trimethylsilane 
• 109-06-8 α-picoline 

Relevant articles and documents

ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS

The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human.

ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS

The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns compounds for use in a method of treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.